170 related articles for article (PubMed ID: 30225168)
1. Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson's disease.
Ashraf-Ganjouei A; Majd A; Javinani A; Aarabi MH
PeerJ; 2018; 6():e5539. PubMed ID: 30225168
[TBL] [Abstract][Full Text] [Related]
2. White Matter Changes Correlates of Peripheral Neuroinflammation in Patients with Parkinson's Disease.
Haghshomar M; Rahmani F; Hadi Aarabi M; Shahjouei S; Sobhani S; Rahmani M
Neuroscience; 2019 Apr; 403():70-78. PubMed ID: 29126955
[TBL] [Abstract][Full Text] [Related]
3. The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.
Stewart CB; Ledingham D; Foster VK; Anderson KN; Sathyanarayana S; Galley D; Pavese N; Pasquini J
Front Neurol; 2023; 14():1155669. PubMed ID: 37122303
[TBL] [Abstract][Full Text] [Related]
4. Exploring white matter microstructure and olfaction dysfunction in early parkinson disease: diffusion MRI reveals new insight.
Sobhani S; Rahmani F; Aarabi MH; Sadr AV
Brain Imaging Behav; 2019 Feb; 13(1):210-219. PubMed ID: 29134611
[TBL] [Abstract][Full Text] [Related]
5. Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder.
Ansari M; Rahmani F; Dolatshahi M; Pooyan A; Aarabi MH
Sleep Breath; 2017 Mar; 21(1):155-161. PubMed ID: 27853964
[TBL] [Abstract][Full Text] [Related]
6. Self-reported autonomic symptoms in Parkinson's disease: properties of the SCOPA-AUT scale.
Bostantjopoulou S; Katsarou Z; Danglis I; Karakasis H; Milioni D; Falup-Pecurariu C
Hippokratia; 2016; 20(2):115-120. PubMed ID: 28416907
[TBL] [Abstract][Full Text] [Related]
7. White matter correlates of disease duration in patients with temporal lobe epilepsy: updated review of literature.
Ashraf-Ganjouei A; Rahmani F; Aarabi MH; Sanjari Moghaddam H; Nazem-Zadeh MR; Davoodi-Bojd E; Soltanian-Zadeh H
Neurol Sci; 2019 Jun; 40(6):1209-1216. PubMed ID: 30868482
[TBL] [Abstract][Full Text] [Related]
8. Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.
Ghazi Sherbaf F; Mohajer B; Ashraf-Ganjouei A; Mojtahed Zadeh M; Javinani A; Sanjari Moghaddam H; Shirin Shandiz M; Aarabi MH
Front Endocrinol (Lausanne); 2018; 9():608. PubMed ID: 30450079
[No Abstract] [Full Text] [Related]
9. The Dysfunctional Autonomic Function and "Dysfunctional" Fatigue in Drug Naïve Parkinson's Disease.
Ahn JH; Kim M; Mun JK; Cho Y; Kim JS; Youn J; Kim JS; Cho JW
J Parkinsons Dis; 2020; 10(2):605-612. PubMed ID: 32250319
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Bulgarian version of Scales for Outcomes in Parkinson's Disease - Autonomic (SCOPA-AUT-BG).
Mantarova SG; Velcheva IV; Georgieva SO; Stambolieva KI
Folia Med (Plovdiv); 2013; 55(3-4):56-62. PubMed ID: 24712283
[TBL] [Abstract][Full Text] [Related]
11. Autonomic dysfunction in Parkinson's disease: Results from the Faroese Parkinson's disease cohort.
Berg A; Bech S; Aasly J; Farrer MJ; Skaalum Petersen M
Neurosci Lett; 2022 Aug; 785():136789. PubMed ID: 35835395
[TBL] [Abstract][Full Text] [Related]
12. Baseline prevalence and longitudinal assessment of autonomic dysfunction in early Parkinson's disease.
Yang L; Gao H; Ye M
J Neural Transm (Vienna); 2024 Feb; 131(2):127-139. PubMed ID: 37923936
[TBL] [Abstract][Full Text] [Related]
13. Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson?
Rahmani F; Aarabi MH
J Neurol; 2017 Apr; 264(4):684-693. PubMed ID: 28168521
[TBL] [Abstract][Full Text] [Related]
14. Comparison of structural connectivity in Parkinson's disease with depressive symptoms versus non-depressed: a diffusion MRI connectometry study.
Ansari M; Adib Moradi S; Ghazi Sherbaf F; Hedayatnia A; Aarabi MH
Int Psychogeriatr; 2019 Jan; 31(1):5-12. PubMed ID: 29560834
[TBL] [Abstract][Full Text] [Related]
15. Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease.
Matsubara T; Suzuki K; Fujita H; Watanabe Y; Sakuramoto H; Matsubara M; Hirata K
Eur Neurol; 2018; 80(3-4):193-199. PubMed ID: 30572329
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Korean Version of the Scale for Outcomes in Parkinson's Disease-Autonomic.
Kim JY; Song IU; Koh SB; Ahn TB; Kim SJ; Cheon SM; Cho JW; Kim YJ; Ma HI; Park MY; Baik JS; Lee PH; Chung SJ; Kim JM; Kim HJ; Sung YH; Kwon DY; Lee JH; Lee JY; Kim JS; Yun JY; Kim HJ; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Kim JS
J Mov Disord; 2017 Jan; 10(1):29-34. PubMed ID: 28122431
[TBL] [Abstract][Full Text] [Related]
17. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT).
Rodriguez-Blazquez C; Forjaz MJ; Frades-Payo B; de Pedro-Cuesta J; Martinez-Martin P;
Eur J Neurol; 2010 Feb; 17(2):194-201. PubMed ID: 19780808
[TBL] [Abstract][Full Text] [Related]
18. Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit.
Yu Z; Li Y;
Medicine (Baltimore); 2021 Feb; 100(7):e24837. PubMed ID: 33607852
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson's disease.
Zhang F; Wang F; Li CH; Wang JW; Han CL; Fan SY; Gao DM; Xing YJ; Yang C; Zhang JG; Meng FG
BMC Neurol; 2022 Mar; 22(1):124. PubMed ID: 35361123
[TBL] [Abstract][Full Text] [Related]
20. Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease.
Sanjari Moghaddam H; Dolatshahi M; Salardini E; Aarabi MH
Neurol Sci; 2019 Feb; 40(2):283-291. PubMed ID: 30386933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
